Tomás Gutiérrez

Tomás Gutiérrez

Auto-generated profile, based on publicly available information

Tomás Gutiérrez

Departments of Biochemistry, University of Alberta, Edmonton, Canada

Research Focus & Metrics

Academic Career Length

15Years (2012-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 January 2012 in The International Journal of Biochemistry & Cell Biology
Verified
Journal Article
Closed access
RBRoberto Bravo-Sagua
Roberto Bravo-Sagua
TGTomás Gutierrez
Tomás Gutierrez
FPFelipe Paredes
Felipe Paredes
DGDamián Gatica
Damián Gatica
ARAndrea E. Rodriguez
Andrea E. Rodriguez
SLSergio Lavandero
Sergio Lavandero

1 January 2014 in Journal of Cell Science
Verified
Journal Article
Open access
PDF file
CPChristian Pennanen
Christian Pennanen
VPValentina Parra
Valentina Parra
CLCamila López-Crisosto
Camila López-Crisosto
PMPablo E. Morales
Pablo E. Morales
ACAndrea del Campo
Andrea del Campo
SLSergio Lavandero
Sergio Lavandero
Cardiomyocyte hypertrophy has been associated with diminished mitochondrial metabolism. Mitochondria are crucial organelles for the production of ATP, and their morphology and function are regulated by the dynamic processes of fusion and fission. The relationship between mitochondrial dynamics and cardiomyocyte hypertrophy is still poorly understood. Here, we show that treatment of cultured neonatal rat cardiomyocytes with the hypertrophic agonist norepinephrine promotes mitochondrial fission (characterized by a decrease in mitochondrial mean volume and an increase in the relative number of mitochondria per cell) and a decrease in mitochondrial function. We demonstrate that norepinephrine acts through α1-adrenergic receptors to increase cytoplasmic Ca2+, activating calcineurin and promoting migration of the fission protein Drp1 (encoded by Dnml1) to mitochondria. Dominant-negative Drp1 (K38A) not only prevented mitochondrial fission, it also blocked hypertrophic growth of cardiomyocytes in response to norepinephrine. Remarkably, an antisense adenovirus against the fusion protein Mfn2 (AsMfn2) was sufficient to increase mitochondrial fission and stimulate a hypertrophic response without agonist treatment. Collectively, these results demonstrate the importance of mitochondrial dynamics in the development of cardiomyocyte hypertrophy and metabolic remodeling.

8 August 2016 in Journal of Cell Biology
Verified
Journal Article
Open access
PDF file
ARArun Raturi
Arun Raturi
TGTomás Gutiérrez
Tomás Gutiérrez
COCarolina Ortiz-Sandoval
Carolina Ortiz-Sandoval
ARAraya Ruangkittisakul
Araya Ruangkittisakul
MHMaria Sol Herrera-Cruz
Maria Sol Herrera-Cruz
TSThomas Simmen
Thomas Simmen
The flux of Ca2+ from the endoplasmic reticulum (ER) to mitochondria regulates mitochondria metabolism. Within tumor tissue, mitochondria metabolism is frequently repressed, leading to chemotherapy resistance and increased growth of the tumor mass. Therefore, altered ER–mitochondria Ca2+ flux could be a cancer hallmark, but only a few regulatory proteins of this mechanism are currently known. One candidate is the redox-sensitive oxidoreductase TMX1 that is enriched on the mitochondria-associated membrane (MAM), the site of ER–mitochondria Ca2+ flux. Our findings demonstrate that cancer cells with low TMX1 exhibit increased ER Ca2+, accelerated cytosolic Ca2+ clearance, and reduced Ca2+ transfer to mitochondria. Thus, low levels of TMX1 reduce ER–mitochondria contacts, shift bioenergetics away from mitochondria, and accelerate tumor growth. For its role in intracellular ER–mitochondria Ca2+ flux, TMX1 requires its thioredoxin motif and palmitoylation to target to the MAM. As a thiol-based tumor suppressor, TMX1 increases mitochondrial ATP production and apoptosis progression.


13 September 2012 in Current Hypertension Reports
Verified
Journal Article
Closed access
PDF file
HVHugo E. Verdejo
Hugo E. Verdejo
ACAndrea del Campo
Andrea del Campo
RTRodrigo Troncoso
Rodrigo Troncoso
TGTomás Gutierrez
Tomás Gutierrez
BTBarbra Toro
Barbra Toro
SLSergio Lavandero
Sergio Lavandero

1 January 2014 in American Journal of Physiology-Endocrinology and Metabolism
Verified
Journal Article
Closed access
PDF file
ACAndrea del Campo
Andrea del Campo
VPValentina Parra
Valentina Parra
CVCésar Alonso Vásquez-Trincado
César Alonso Vásquez-Trincado
TGTomás Gutiérrez
Tomás Gutiérrez
PMPablo E. Morales
Pablo E. Morales
SLSergio Lavandero
Sergio Lavandero
Insulin is a major regulator of glucose metabolism, stimulating its mitochondrial oxidation in skeletal muscle cells. Mitochondria are dynamic organelles that can undergo structural remodeling in order to cope with these ever-changing metabolic demands. However, the process by which mitochondrial morphology impacts insulin signaling in the skeletal muscle cells remains uncertain. To address this question, we silenced the mitochondrial fusion proteins Mfn2 and Opa1 and assessed insulin-dependent responses in L6 rat skeletal muscle cells. We found that mitochondrial fragmentation attenuates insulin-stimulated Akt phosphorylation, glucose uptake and cell respiratory rate. Importantly, we found that insulin induces a transient rise in mitochondrial Ca2+ uptake, which was attenuated by silencing Opa1 or Mfn2. Moreover, treatment with Ruthenium red, an inhibitor of mitochondrial Ca2+ uptake, impairs Akt signaling without affecting mitochondrial dynamics. All together, these results suggest that control of mitochondrial Ca2+ uptake by mitochondrial morphology is a key event for insulin-induced glucose uptake.